the waiting for revenue should soon be over ...... cheap placement or not, slt will be cashed up and have revenue. this should be the bottom.
incidentally, this from chiron website: No biotech company has had a greater impact on human health worldwide than Chiron. As a multi-dimensional company with businesses in biopharmaceuticals, vaccines and blood testing, Chiron has been at the forefront of improving lives around the globe. By developing new products, exploring new indications for existing products and expanding our market reach, Chiron will continue to bring improvement to health around the globe. www.chiron.com
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
